US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iPath Select MLP ETN

36.61

-0.0916-0.25%

Volume:5K

Turnover:179.99K

Market Cap:687.08M

PE:- -

High:36.61

Open:36.49

Low:36.45

Close:36.70

52wk High:37.38

52wk Low:27.23

Shares:18.77M

Float Shares:18.77M

Volume Ratio:0.41

T/O Rate:0.03%

Dividend:1.58

Dividend Rate:4.32%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Canadian Energy Infrastructure Firm Enbridge Remains Upbeat on Growth Potential Despite Weaker Q2 Earnings

The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy

Barclays Bank PLC Files SEC-Compliant Interim Results for First Half of 2026

Barclays Bank Files Form 6-K and Publishes 2026 Interim Results on National Storage Mechanism

SINOPEC SSC Subsidiary Wins Bid for Key Section of Major Natural Gas Pipeline Project

ATMP Aminotrimethylenephosphonic Acid Price Update (May 16, 2026)

Capricor Therapeutics Announces Late-Breaking Presentation of HOPE-3 Phase 3 Results at the American Academy of Neurology 2026 Annual Meeting

VERIGRAFT Advances First Potential Curative Treatment for CVI into Pivotal Phase II/III Trial

Belief BioMed announced BBM-H901 (Dalnacogene Ponparvovec Injection), China's first hemophilia B gene therapy, was officially approved in Macao, China

Capricor Therapeutics Announces Establishment of New PDUFA Date for Deramiocel BLA

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/ATMP/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ATMP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATMP\",,,,,undefined,":{"symbol":"ATMP","market":"US","secType":"STK","nameCN":"iPath Select MLP ETN","latestPrice":36.6099,"timestamp":1787587213787,"preClose":36.7015,"halted":0,"volume":4933,"delay":0,"changeRate":-0.0024958107979237815,"floatShares":18767506,"shares":18767506,"eps":0,"marketStatus":"Trading","change":-0.0916,"latestTime":"08-24 12:12:20 EDT","open":36.49,"high":36.6099,"low":36.45,"amount":179988.654316,"amplitude":0.004357,"askPrice":36.66,"askSize":1200,"bidPrice":36.6,"bidSize":1900,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787601600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"CBOE","adjPreClose":36.7015,"sharesOutstanding":18317506,"nav":36.7449,"aum":689518170.44,"dividendRate":0.04321,"bidAskSpread":0.001678,"postHourTrading":{"tag":"盘后","latestPrice":36.66,"preClose":36.7015,"latestTime":"19:30 EDT","volume":9,"amount":330.3135,"timestamp":1787355004837,"change":-0.0415,"changeRate":-0.001131,"amplitude":0},"volumeRatio":0.410852,"impliedVol":0.0349,"impliedVolPercentile":0.2072},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATMP\",,,,,undefined,":{"symbol":"ATMP","floatShares":18767506,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.410852,"shares":18767506,"dividePrice":1.5819,"high":36.6099,"amplitude":0.004357,"preClose":36.7015,"low":36.45,"week52Low":27.23,"pbRate":"--","week52High":37.38,"institutionHeld":0,"latestPrice":36.6099,"committee":0.225806,"eps":0,"divideRate":0.04321,"volume":4933,"delay":0,"ttmEps":0,"open":36.49,"prevYearClose":28.77,"prevWeekClose":36.7015,"prevMonthClose":36.3121,"prevQuarterClose":34.523,"fiveDayClose":36.6375,"twentyDayClose":35.7988,"sixtyDayClose":34.92},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ATMP\",params:#limit:5,,,undefined,":[{"date":"2026-08-28","symbol":"ATMP","amount":0.39996,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-28","defaultRemindTime":1787923800000,"name":"iPath Select MLP ETN","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-08","payableDate":"2026-08-28","currency":"USD","dateTimestamp":1787889600000,"payDate":"2026-09-08"},{"date":"2026-05-29","symbol":"ATMP","amount":0.40882,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-05-29","defaultRemindTime":1780061400000,"name":"iPath Select MLP ETN","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-08","payableDate":"2026-05-29","currency":"USD","dateTimestamp":1780027200000,"payDate":"2026-06-08"},{"date":"2026-03-02","symbol":"ATMP","amount":0.392948056,"announcedDate":"2026-02-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-02","defaultRemindTime":1772461800000,"name":"iPath Select MLP ETN","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-10","payableDate":"2026-03-02","currency":"USD","dateTimestamp":1772427600000,"payDate":"2026-03-10"},{"date":"2025-12-01","symbol":"ATMP","amount":0.39806809,"announcedDate":"2025-11-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-01","defaultRemindTime":1764599400000,"name":"iPath Select MLP ETN","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-09","payableDate":"2025-12-01","currency":"USD","dateTimestamp":1764565200000,"payDate":"2025-12-09"},{"date":"2025-08-28","symbol":"ATMP","amount":0.381190999,"announcedDate":"2025-08-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-08-28","defaultRemindTime":1756387800000,"name":"iPath Select MLP ETN","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-08","payableDate":"2025-08-28","currency":"USD","dateTimestamp":1756353600000,"payDate":"2025-09-08"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ATMP\",market:\"US\",,,undefined,":[{"executeDate":"2017-02-27","recordDate":null,"paymentDate":null,"value":0.2845092,"currency":"USD"},{"executeDate":"2017-05-24","recordDate":null,"paymentDate":null,"value":0.2714382,"currency":"USD"},{"executeDate":"2017-08-24","recordDate":null,"paymentDate":null,"value":0.302208,"currency":"USD"},{"executeDate":"2017-11-28","recordDate":null,"paymentDate":null,"value":0.2959505,"currency":"USD"},{"executeDate":"2018-02-28","recordDate":null,"paymentDate":null,"value":0.2574755,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ATMP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1579,"buy":0.6842,"hold":0.1579,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6842,"analysts":19,"updateTime":1782273600000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ATMP\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1184998626","title":"Canadian Energy Infrastructure Firm Enbridge Remains Upbeat on Growth Potential Despite Weaker Q2 Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=1184998626","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184998626?lang=en_us&edition=fundamental","pubTime":"2026-07-31 20:20","pubTimestamp":1785500423,"startTime":"0","endTime":"0","summary":"Canadian oil and gas infrastructure company Enbridge has signaled that conditions remain favorable for growth, even amid a challenging macroeconomic backdrop. The firm reported second-quarter...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVIR","ATMP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655896416","title":"The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy","url":"https://stock-news.laohu8.com/highlight/detail?id=2655896416","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655896416?lang=en_us&edition=fundamental","pubTime":"2026-07-29 22:05","pubTimestamp":1785333900,"startTime":"0","endTime":"0","summary":"--Independent Peer Review Provides External Validation of the Trial's Design, Statistical Methodology and Findings-- --Randomized, Double-Blind, Placebo-Controlled HOPE-3 Phase 3 Trial (n=106) Met Pri","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/29/3335380/0/en/The-Lancet-Publishes-HOPE-3-Data-for-Capricor-Therapeutics-Deramiocel-in-Duchenne-Muscular-Dystrophy.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAPR","HOPE","BK4211","ATMP","BK4139","BK4081","EMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655889431","title":"Barclays Bank PLC Files SEC-Compliant Interim Results for First Half of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2655889431","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655889431?lang=en_us&edition=fundamental","pubTime":"2026-07-29 00:57","pubTimestamp":1785257849,"startTime":"0","endTime":"0","summary":"Barclays ETN+ Select MLP ETN ( ($ATMP) ) has provided an update. Barclays Bank PLC has filed a Form 6-K with the U.S. Securities and Exchange Commi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/barclays-bank-plc-files-sec-compliant-interim-results-for-first-half-of-2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/barclays-bank-plc-files-sec-compliant-interim-results-for-first-half-of-2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATMP","EIPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654405007","title":"Barclays Bank Files Form 6-K and Publishes 2026 Interim Results on National Storage Mechanism","url":"https://stock-news.laohu8.com/highlight/detail?id=2654405007","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654405007?lang=en_us&edition=fundamental","pubTime":"2026-07-28 21:18","pubTimestamp":1785244731,"startTime":"0","endTime":"0","summary":"An announcement from Barclays ETN+ Select MLP ETN ( ($ATMP) ) is now available. Barclays Bank PLC, a major international banking group based in Lon...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/barclays-bank-files-form-6-k-and-publishes-2026-interim-results-on-national-storage-mechanism?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/barclays-bank-files-form-6-k-and-publishes-2026-interim-results-on-national-storage-mechanism?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VQT","ATMP","IXG","BK4582","NHLD","EIPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194362941","title":"SINOPEC SSC Subsidiary Wins Bid for Key Section of Major Natural Gas Pipeline Project","url":"https://stock-news.laohu8.com/highlight/detail?id=1194362941","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194362941?lang=en_us&edition=fundamental","pubTime":"2026-07-07 16:23","pubTimestamp":1783412595,"startTime":"0","endTime":"0","summary":"An announcement has been issued by SINOPEC SSC (01033) regarding a significant contract win.The company's wholly-owned subsidiary, Sinopec Petroleum Engineering Construction Co., Ltd., has been...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMJB","AMUB","MLPA","BK4585","01033","AMLP","BK1562","UMI","MLPR","ATMP","GII","EMLP","NFRA","ENFR","IGF","TPYP","BK1202","BK4588","MLPB","UNL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189396924","title":"ATMP Aminotrimethylenephosphonic Acid Price Update (May 16, 2026)","url":"https://stock-news.laohu8.com/highlight/detail?id=1189396924","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189396924?lang=en_us&edition=fundamental","pubTime":"2026-05-16 20:20","pubTimestamp":1778934051,"startTime":"0","endTime":"0","summary":"Latest market quotations for ATMP Aminotrimethylenephosphonic Acid (50% National Standard) are provided.\nSupplier: Shandong Jinshengrun Chemical Co., Ltd.\nBrand/Origin: Shandong\nDelivery Location: Jinan City, Shandong Province\nLatest Quoted Price: 5600 RMB per ton","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATMP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629727041","title":"Capricor Therapeutics Announces Late-Breaking Presentation of HOPE-3 Phase 3 Results at the American Academy of Neurology 2026 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2629727041","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629727041?lang=en_us&edition=fundamental","pubTime":"2026-04-22 21:00","pubTimestamp":1776862800,"startTime":"0","endTime":"0","summary":"SAN DIEGO, April  22, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for rare diseases, today anno","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/22/3279030/0/en/Capricor-Therapeutics-Announces-Late-Breaking-Presentation-of-HOPE-3-Phase-3-Results-at-the-American-Academy-of-Neurology-2026-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AFG","BK4081","BK4139","BK4178","BK4117","CAPR","AAN","HOPE","BK4211","ATMP","EMA","BK4107"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622639022","title":"VERIGRAFT Advances First Potential Curative Treatment for CVI into Pivotal Phase II/III Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2622639022","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622639022?lang=en_us&edition=fundamental","pubTime":"2026-03-25 18:19","pubTimestamp":1774433940,"startTime":"0","endTime":"0","summary":"Pivotal Phase II/III clinical trial underway, aiming for US and European market approval in 2028. A 'truly transformative' regenerative medicine targeting a multi-million patient population with no existing curative treatment. Fully biological transplant eliminates need for immunosuppression and restores natural function. CVI market projected to reach USD 5,951 million by 2034*. Supported by USD 10 million financing from existing investors. GOTHENBURG, Sweden, March 25, 2026 /PRNewswire/ -- VERIGRAFT, a Swedish clinical-stage biotechnology company pioneering personalized, fully biological therapies, today announced the initiation of a pivotal Phase II/III trial of its P-TEV  in patients with chronic venous insufficiency , supported by USD 10 million from existing investors.The milestone comes at a time when regenerative medicine and personalized biologics are gaining significant traction among global investors and healthcare systems.Restorative effect of replacing diseased vein with fu","market":"nz","thumbnail":"https://mma.prnewswire.com/media/2942028/VERIGRAFT_P_TEV.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2942028/VERIGRAFT_P_TEV.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/verigraft-advances-first-potential-curative-treatment-for-cvi-into-pivotal-phase-iiiii-trial-302724707.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVI","LU1878469433.USD","BK4141","III","BK4138","ATMP","PI","BK4134"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620896241","title":"Belief BioMed announced BBM-H901 (Dalnacogene Ponparvovec Injection), China's first hemophilia B gene therapy, was officially approved in Macao, China","url":"https://stock-news.laohu8.com/highlight/detail?id=2620896241","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620896241?lang=en_us&edition=fundamental","pubTime":"2026-03-19 18:27","pubTimestamp":1773916020,"startTime":"0","endTime":"0","summary":"SHANGHAI, March 19, 2026 /PRNewswire/ -- Belief BioMed  today announced that BBM-H901 , has been officially approved by the Pharmaceutical Administration Bureau of Macao Special Administrative Region of China for the treatment of adult patients with moderate to severe hemophilia B . This product is developed and manufactured by BBM, and Takeda China is responsible for its commercialization in mainland China, Hong Kong, China and Macao, China. Following its approval in mainland China in April 2025 as the country's first gene therapy for hemophilia B, [1] the recent approval of BBM-H901 in Macao, China, not only addresses the previously unmet medical need for such treatment in the region but also marks a crucial step in accelerating the global availability of this breakthrough gene therapy.BBM-H901 is a gene therapy drug based on a recombinant adeno-associated virus  vector. It can precisely deliver the high-activity FIX gene into the liver cells of patients, enabling the sustained and h","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/belief-biomed-announced-bbm-h901-dalnacogene-ponparvovec-injection-chinas-first-hemophilia-b-gene-therapy-was-officially-approved-in-macao-china-302718633.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4129","BLA.AU","BK4081","EMA","BK4109","ABR","ATMP","ASH","BK7057","LU0053671581.USD","BK7129","LU2463526074.USD","BK7095","ODD","ABR.AU","LU0054578231.USD","LU0963586101.USD","BK4183","BK4567","BK7504","BK4110","IE0009354923.USD","ASH.AU","EMA.AU","FIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618956571","title":"Capricor Therapeutics Announces Establishment of New PDUFA Date for Deramiocel BLA","url":"https://stock-news.laohu8.com/highlight/detail?id=2618956571","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618956571?lang=en_us&edition=fundamental","pubTime":"2026-03-10 21:25","pubTimestamp":1773149100,"startTime":"0","endTime":"0","summary":"Deramiocel has the potential to become the first therapy to address both skeletal and cardiac manifestations of Duchenne muscular dystrophyBLA supported by positive pivotal HOPE-3 Phase 3 results, inc","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/10/3252978/0/en/Capricor-Therapeutics-Announces-Establishment-of-New-PDUFA-Date-for-Deramiocel-BLA.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","ATMP","BK4585","BK4139","LABU","BK4081","CAPR","EMA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}]}}